Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salmonella enterica serovar Enteritidis outer membrane antigens are a collection of surface-associated molecules, principally outer membrane proteins (such as OmpA, OmpD, FliD, PgtE) and lipopolysaccharide (LPS) O-antigen, that form the interface between the bacterium and host environment[2][3][4][6][7]. These antigens are essential for bacterial survival, virulence, and immune evasion, mediating functions like structural integrity of the bacterial cell, adhesion to host cells, and resistance to the host immune response, particularly complement-mediated killing. Outer membrane antigens, notably OMPs and OAg, are prime candidates for vaccine development and are under investigation as biomarkers for infection and as immunogens capable of eliciting protective immunity[4][7]. The antigenic variability across different strains poses a challenge to broadly protective interventions, but these outer membrane antigens remain primary targets for antibacterial immunity, diagnostics, and vaccine strategies. Key proteins and features: - OmpA: Structural and immunogenic, involved in host immune recognition[3]. - OmpD: Important for antibody access and vaccine-induced protection, but OmpD-O-antigen interactions limit cross-serovar efficacy[7]. - PgtE: Outer membrane protease that degrades complement components, conferring serum resistance and enhancing survival in host tissues[2][3]. - FliD: Flagellar hook-associated protein, implicated in adhesion and immunogenicity[3]. - Lipopolysaccharide (LPS) O-antigen: Defines serovar, acts as a key surface antigen and barrier, varies among serovars (O:9 antigen in S. Enteritidis)[4][7]. Vaccine candidates, such as GMMA (Generalized Modules for Membrane Antigens), utilize these native outer membrane antigens to stimulate broad and functional immune responses[4]. LPS and protein antigens are also being actively investigated as immunodiagnostics and research biomarkers for infection with this pathogen.
Induction of opsonophagocytosis and complement-mediated killing via antibody recognition; Prevention of complement activation (e.g., PgtE-mediated cleavage of complement proteins); Promotion of immune responses through antigen presentation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella enterica serovar Enteritidis outer membrane antigen.